SOTYKTU IS ONE OF A KIND

As a selective TYK2 inhibitor, no other once-daily pill works like SOTYKTU

Actor portrayal of a SOTYKTU® patient, smiling.
SOTYKTU® is a pill for adults with moderate to severe plaque psoriasis that only needs to be taken once a day.

WHEN TOPICALS AREN’T ENOUGH, ASK FOR SOTYKTU

THE ONLY ONCE-DAILY ORAL MEDICATION FOR CHRONIC MODERATE TO SEVERE PLAQUE PSORIASIS THAT TREATS FROM WITHIN
  • SOTYKTU is an oral prescription pill for adults with moderate to severe plaque psoriasis
  • Because SOTYKTU treats from within, take it every day as prescribed, even when you’re not flaring
  • SOTYKTU can fit your lifestyle—YOU decide when and where to take it

SOTYKTU TREATS PLAQUE PSORIASIS WHERE IT STARTS: INSIDE THE BODY

HERE’S HOW IT WORKS…

  • With plaque psoriasis, the immune system can become “overactive” and create inflammation, ultimately sending signals that cause skin cells to grow too fast
  • SOTYKTU helps decrease those signals by selectively targeting and blocking TYK2
  • TYK2 is a molecule within your immune system that plays a key role in passing on signals in psoriasis

SOTYKTU IS THE ONLY FDA-APPROVED
ONCE-DAILY PILL THAT WORKS THIS WAY

It is not well defined how blocking TYK2 helps psoriasis symptoms.

 

SOTYKTU® works by blocking TYK2 proteins which send signals that create inflammation and cause plaques on the skin.
Real SOTYKTYU® patient Solmarye stands smiling with her hand on her hip.

I’ve tried topicals but SOTYKTU treats my psoriasis from the inside and it has been effective for me.

Solmarye, currently taking SOTYKTU
Solmarye is a real patient on SOTYKTU compensated for her time. Results may vary.

SO

HERE'S A QUESTION...

Loading...

SOTYKTU BY THE NUMBERS

More than 800 people received SOTYKTU in clinical trials

STAY IN THE KNOW

Have a SOTYKTU prescription?
Sign up for ongoing support.



Bristol Myers Squibb corporate website

SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU logo are trademarks of Bristol-Myers Squibb Company.
All other trademarks are property of their respective owners.
© 2025 Bristol-Myers Squibb Company.

This website is intended for U.S. residents 18 years of age or older.

1787-US-2500206 07/25